Position in ACAD
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$3,624,373
-$601,068 QoQ
Shares Held
162,820
+2.9% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALPS ADVISORS INC holds $156,743,120 across 93 Biotechnology names. ACAD ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
496,682 | $23,825,835 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
66,457 | $5,535,203 | |
| 3 | CGON |
CG Oncology, Inc.
|
68,737 | $4,652,120 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
49,128 | $4,538,444 | |
| 5 | CELC |
Celcuity Inc.
|
37,663 | $4,298,854 | |
| 6 | APLS |
Apellis Pharmaceuticals, Inc.
|
104,058 | $4,186,253 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
67,723 | $3,938,092 | |
| 8 | APGE |
Apogee Therapeutics, Inc.
|
45,586 | $3,836,973 |
All Filings in ACAD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,624,373 | 162,820 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $4,225,441 | 158,197 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,130,030 | 99,814 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,413,575 | 111,895 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,329,137 | 140,225 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $2,468,882 | 134,544 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,954,736 | 127,096 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,094,072 | 128,866 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,148,944 | 116,222 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,498,360 | 111,733 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,517,680 | 120,810 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,862,887 | 119,536 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,011,538 | 106,883 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $1,746,487 | 109,704 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,445,667 | 88,366 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,331,279 | 94,484 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,012,793 | 165,681 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,342,266 | 186,044 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $3,270,409 | 196,894 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,126,265 | 210,179 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||